1. Mesholam-Gately RI, Giuliano AJ, Goff KP, Faraone SV, Seidman LJ. Neurocognition in first-episode schizophrenia: a meta-analytic review. Neuropsychology 2009;23:315-336. PMID:
19413446.
2. Nieuwenstein MR, Aleman A, de Haan EH. Relationship between symptom dimensions and neurocognitive functioning in schizophrenia: a meta-analysis of WCST and CPT studies. Wisconsin Card Sorting Test. Continuous Performance Test. J Psychiatr Res 2001;35:119-125. PMID:
11377441.
3. Corigliano V, De Carolis A, Trovini G, Dehning J, Di Pietro S, Curto M, et al. Neurocognition in schizophrenia: from prodrome to multi-episode illness. Psychiatry Res 2014;220:129-134. PMID:
25149131.
4. Berman I, Viegner B, Merson A, Allan E, Pappas D, Green AI. Differential relationships between positive and negative symptoms and neuropsychological deficits in schizophrenia. Schizophr Res 1997;25:1-10. PMID:
9176922.
5. Verdoux H, Liraud F, Assens F, Abalan F, van Os J. Social and clinical consequences of cognitive deficits in early psychosis: a two-year follow-up study of first-admitted patients. Schizophr Res 2002;56:149-159. PMID:
12084429.
6. Green MF, Kern RS, Heaton RK. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr Res 2004;72:41-51. PMID:
15531406.
7. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry 2008;165:203-213. PMID:
18172019.
8. Green MF, Nuechterlein KH, Kern RS, Baade LE, Fenton WS, Gold JM, et al. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS Psychometric and Standardization Study. Am J Psychiatry 2008;165:221-228. PMID:
18172017.
9. Keefe RS, Poe M, Walker TM, Kang JW, Harvey PD. The Schizophrenia Cognition Rating Scale: an interview-based assessment and its relationship to cognition, real-world functioning, and functional capacity. Am J Psychiatry 2006;163:426-432. PMID:
16513863.
10. Ventura J, Cienfuegos A, Boxer O, Bilder R. Clinical global impression of cognition in schizophrenia (CGI-CogS): reliability and validity of a co-primary measure of cognition. Schizophr Res 2008;106:59-69. PMID:
17900866.
11. Patterson TL, Goldman S, McKibbin CL, Hughs T, Jeste DV. UCSD Performance-Based Skills Assessment: development of a new measure of everyday functioning for severely mentally ill adults. Schizophr Bull 2001;27:235-245. PMID:
11354591.
12. Bellack AS, Sayers M, Mueser KT, Bennett M. Evaluation of social problem solving in schizophrenia. J Abnorm Psychol 1994;103:371-378. PMID:
8040506.
13. Keefe RS, Davis VG, Spagnola NB, Hilt D, Dgetluck N, Ruse S, et al. Reliability, validity and treatment sensitivity of the Schizophrenia Cognition Rating Scale. Eur Neuropsychopharmacol 2015;25:176-184. PMID:
25028065.
14. Chia MY, Chan WY, Chua KY, Lee H, Lee J, Lee R, et al. The Schizophrenia Cognition Rating Scale: validation of an interview-based assessment of cognitive functioning in Asian patients with schizophrenia. Psychiatry Res 2010;178:33-38. PMID:
20451258.
15. Kaneda Y, Ueoka Y, Sumiyoshi T, Yasui-Furukori N, Ito T, Higuchi Y, et al. Schizophrenia Cognition Rating Scale Japanese version (SCoRS-J) as a co-primary measure assessing cognitive function in schizophrenia. Nihon Shinkei Seishin Yakurigaku Zasshi 2011;31:259-262. PMID:
22256616.
16. American Psychiatric Association. D. S. M. Task Force. Diagnostic and Statistical Manual of Mental Disorders: DSM-5. Washington, D.C.: American Psychiatric Publishing; 2013.
17. Bonett DG, Wright TA. Sample size requirements for estimating pearson, kendall and spearman correlations. Psychometrika 2000;65:23-28.
18. Rey MJ, Schulz P, Costa C, Dick P, Tissot R. Guidelines for the dosage of neuroleptics. I: Chlorpromazine equivalents of orally administered neuroleptics. Int Clin Psychopharmacol 1989;4:95-104. PMID:
2568378.
19. Gardner DM, Murphy AL, O'Donnell H, Centorrino F, Baldessarini RJ. International consensus study of antipsychotic dosing. Am J Psychiatry 2010;167:686-693. PMID:
20360319.
20. Allen DN, Huegel SG, Gurklis JA Jr, Kelley ME, Barry EJ, van Kammen DP. Utility of WAIS-R short forms in schizophrenia. Schizophr Res 1997;26:163-172. PMID:
9323347.
21. Heaton RK, Chelune GJ, Talley JL, Kay GG, Curtiss G. Wisconsin Card Sorting Test, Manual: Revised and Expanded. Odessa, Florida: Psychological Assessment Resources; 1993.
22. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276. PMID:
3616518.
23. Yi JS, Ahn YM, Shin HK, An SK, Joo YH, Kim SH, et al. Reliability and validity of the korean version of the positive and negative syndrome scale. J Korean Neuropsychiatr Assoc 2001;40:1090-1105.
24. van der Gaag M, Hoffman T, Remijsen M, Hijman R, de Haan L, van Meijel B, et al. The five-factor model of the Positive and Negative Syndrome Scale II: a ten-fold cross-validation of a revised model. Schizophr Res 2006;85:280-287. PMID:
16730429.
25. Haro JM, Kamath SA, Ochoa S, Novick D, Rele K, Fargas A, et al. The Clinical Global Impression-Schizophrenia scale: a simple instrument to measure the diversity of symptoms present in schizophrenia. Acta Psychiatr Scand Suppl 2003;16-23. PMID:
12755850.
26. Birchwood M, Smith J, Cochrane R, Wetton S, Copestake S. The Social Functioning Scale. The development and validation of a new scale of social adjustment for use in family intervention programmes with schizophrenic patients. Br J Psychiatry 1990;157:853-859. PMID:
2289094.
27. Kim CK, Lee JA. Development of the Korean version of the social functioning scale in the schizophrenics: a study on the reliability and validity. Korean J Biol Psychiatry 2009;16:76-111.
28. Martin CR, Allan R. Factor structure of the Schizophrenia Quality of Life Scale Revision 4 (SQLS-R4). Psychol Health Med 2007;12:126-134. PMID:
17365893.
29. Kim JH, Yim SJ, Min SK, Kim SE, Son SJ, Wild DJ, et al. The Korean version of 4th revision of schizophrenia quality of life scale: validation study and relationship with PANSS. J Korean Neuropsychiatr Assoc 2006;45:401-410.
30. Goldman HH, Skodol AE, Lave TR. Revising axis V for DSM-IV: a review of measures of social functioning. Am J Psychiatry 1992;149:1148-1156. PMID:
1386964.
31. Liddle PF. Schizophrenic syndromes, cognitive performance and neurological dysfunction. Psychol Med 1987;17:49-57. PMID:
3575577.
32. Cuesta MJ, Peralta V. Cognitive disorders in the positive, negative, and disorganization syndromes of schizophrenia. Psychiatry Res 1995;58:227-235. PMID:
8570778.
33. Strauss ME. Relations of symptoms to cognitive deficits in schizophrenia. Schizophr Bull 1993;19:215-231. PMID:
8322033.